Free Trial

Mirum Pharmaceuticals (MIRM) Insider Trading & Ownership

Mirum Pharmaceuticals logo
$41.51 +0.38 (+0.92%)
(As of 12/20/2024 05:16 PM ET)

Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.87%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$115,064.40
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$1.66 M
Get MIRM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mirum Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MIRM Insider Buying and Selling by Quarter

Mirum Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2024Jolanda HoweSVPSell2,500$47.10$117,750.00  
9/18/2024Patrick J HeronDirectorBuy115$37.40$4,301.00  
9/6/2024Patrick J HeronDirectorBuy230$41.58$9,563.40  
7/2/2024Jolanda HoweSVPSell375$34.00$12,750.00  
6/24/2024Pamela VigInsiderSell30,559$34.00$1,039,006.00  
6/5/2024Saira RamasastryDirectorSell5,000$25.68$128,400.00  
3/27/2024Eric BjerkholtCFOBuy2,000$24.80$49,600.00  
3/25/2024Peter RadovichCOOSell4,303$25.80$111,017.40  
3/18/2024Eric BjerkholtCFOBuy2,000$25.80$51,600.00  
2/2/2024Jolanda HoweSVPSell735$26.19$19,249.65  
1/8/2024Christopher PeetzCEOSell5,209$28.03$146,008.27  
1/8/2024Jolanda HoweSVPSell528$28.04$14,805.12  
1/8/2024Lara LongpreInsiderSell1,019$28.04$28,572.76  
1/8/2024Peter RadovichCOOSell1,408$28.03$39,466.24  
(Data available from 1/1/2013 forward)

MIRM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Mirum Pharmaceuticals includes Christopher Peetz, Eric Bjerkholt, James E Flynn, Jolanda Howe, Lara Longpre, Michael G. Grey, Niall O'donnell, Pamela Vig, Patrick J Heron, Peter Radovich, and Saira Ramasastry. Learn more on insiders at MIRM.

22.87% of Mirum Pharmaceuticals stock is owned by insiders. Learn more on MIRM's insider holdings.

The following insiders have purchased MIRM shares in the last 24 months: Eric Bjerkholt ($397,700.00), and Patrick J Heron ($4,040,644.25).

Insiders have purchased a total of 167,023 MIRM shares in the last 24 months for a total of $4,438,344.25 bought.

The following insiders have sold MIRM shares in the last 24 months: Christopher Peetz ($287,031.97), Jolanda Howe ($359,754.09), Lara Longpre ($54,325.36), Michael G. Grey ($863,936.00), Pamela Vig ($1,039,006.00), Peter Radovich ($187,034.89), and Saira Ramasastry ($128,400.00).

Insiders have sold a total of 95,261 Mirum Pharmaceuticals shares in the last 24 months for a total of $2,919,488.31 sold.

Mirum Pharmaceuticals Key Executives

  • Mr. Christopher PeetzMr. Christopher Peetz (Age 45)
    Co-Founder, CEO and Director
    Compensation: $1.31M
  • Mr. Peter Radovich M.B.A. (Age 46)
    Ph.D., COO & President
    Compensation: $881.8k
  • Mr. Eric H. Bjerkholt M.B.A. (Age 64)
    Chief Financial Officer
    Compensation: $600.4k
  • Dr. Pamela Vig Ph.D. (Age 53)
    Chief Scientific Officer
    Compensation: $678.2k
  • Andrew McKibben
    Vice President of Investor Relations and Finance
  • Mr. Paul K. Ross
    Chief Compliance Officer
  • Ms. Erin Campany (Age 56)
    Senior Vice President of Human Resources
  • Ms. Lara Longpre MBA (Age 54)
    MSC, Chief Development Officer
    Compensation: $678.2k
  • Ms. Vinita P. Kumar
    Senior vice President of Quality
  • Dr. Jean-Luc Girardet Ph.D.
    Senior Vice President of Technical Operations


This page (NASDAQ:MIRM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners